Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.265 USD | +4.38% | -1.30% | +17.01% |
Mar. 04 | North American Morning Briefing : Stock Futures -2- | DJ |
Feb. 28 | Lyell Immunopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.27% | 553M | |
-2.54% | 102B | |
+2.33% | 96.09B | |
+2.13% | 22.28B | |
-17.07% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.83% | 16.09B | |
+6.38% | 13.83B | |
+32.58% | 11.97B |
- Stock Market
- Equities
- LYEL Stock
- News Lyell Immunopharma, Inc.
- Morgan Stanley Downgrades Lyell Immunopharma to Equalweight From Overweight, Adjusts Price Target to $7 From $15